Search Login Register

trastuzumab (Herceptin) Summary

Description: a HER2 antibody that lengthens remission time in metastatic breast cancer

Also Known As: Herceptin; Genentech brand of trastuzumab; Hoffman-La Roche brand of trastuzumab; Roche brand of trastuzumab

Networked: 4677 relevant articles (791 outcomes, 1237 trials/studies) for this Drug

Key Diseases for which trastuzumab is Relevant

  1. Breast Neoplasms (Breast Cancer) : 523 outcomes 835 studies in 3210 results
  2. Neoplasms (Cancer) : 183 outcomes 285 studies in 1655 results
  3. Stomach Neoplasms (Stomach Cancer) : 62 outcomes 77 studies in 272 results
  4. Neoplasm Metastasis (Metastasis) : 43 outcomes 33 studies in 300 results
  5. Carcinoma (Carcinomatosis) : 26 outcomes 44 studies in 270 results
Show All >>

Drugs Related to trastuzumab

  1. trastuzumab (Herceptin)
  2. Epidermal Growth Factor Receptor (EGF Receptor)
  3. lapatinib (GW572016)
  4. docetaxel (Taxotere)
  5. Paclitaxel (Taxol)
  6. pertuzumab
  7. capecitabine (Xeloda)
  8. Epidermal Growth Factor (EGF)
  9. taxane
  10. vinorelbine (Navelbine)
Show All >>

Therapies Related to trastuzumab

  1. Drug Therapy (Chemotherapy)
  2. Heterologous Transplantation (Xenotransplantation)
  3. Adjuvant Chemotherapy
  4. Neoadjuvant Therapy
  5. Radiotherapy
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.